Mar 11, 2026
Therapeutic Interchange: What Providers Really Mean When They Suggest a Different Drug
Tag: interchangeability designation
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026
Read More
Explore how the FDA reviews biosimilars under the new 2025 guidance. Learn about the shift from clinical trials to analytical characterization, interchangeability rules, and what this means for patient access and drug costs.
